Massachusetts General Hospital
- Consultant: Abbott Laboratories; AstraZeneca LP; Eli Lilly and Company; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; National Institutes of Health; National Institute on Drug Abuse; Novartis Pharmaceutical Corporation; Shire Pharmaceuticals Inc.
- Grant Support: Abbott Laboratories; AstraZeneca LP; Eli Lilly and Company; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; National Institutes of Health; National Institute on Drug Abuse; Novartis Pharmaceutical Corporation; Shire Pharmaceuticals Inc.
- Honorarium for participation in this meeting: American Academy of Child & Adolescent Psychiatry
- Research Support: AstraZeneca LP
- Speakers Bureau: Eli Lilly and Company; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; National Institutes of Health; National Institute on Drug Abuse; Novartis Pharmaceutical Corporation; Shire Pharmaceuticals Inc.